Pharmacological management of co-morbid conditions at the end of life: is less more?
AffiliationSpecialist Palliative Care Service, Dochas Centre, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland. email@example.com
Kidney Failure, Chronic
Peripheral Vascular Diseases
Pulmonary Disease, Chronic Obstructive
MetadataShow full item record
CitationPharmacological management of co-morbid conditions at the end of life: is less more? 2013, 182 (1):107-12 Ir J Med Sci
JournalIrish journal of medical science
AbstractCo-morbid conditions (CMCs) are present in over half of patients with cancer over 50 years of age. As life-limiting illnesses progress, the benefits and burdens of treatments for CMCs become unclear. Relevant issues include physiological changes in advanced illness, time-to-benefit of medications, burden of medications, and psychological impact of discontinuing medications. Optimal prescribing is unclear due to lack of evidence.
- Prescribing in palliative care as death approaches.
- Authors: Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM
- Issue date: 2007 Apr
- The Burden of Polypharmacy in Patients Near the End of Life.
- Authors: McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP
- Issue date: 2016 Feb
- Inappropriate prescribing in patients accessing specialist palliative day care services.
- Authors: Todd A, Nazar H, Pearson H, Andrew L, Baker L, Husband A
- Issue date: 2014 Jun
- Prescribing for comorbid disease in a palliative population: focus on the use of lipid-lowering medications.
- Authors: Russell BJ, Rowett D, Abernethy AP, Currow DC
- Issue date: 2014 Feb
- Prescribing in the oldest old inpatients: a retrospective analysis of patients referred for specialist geriatric consultation.
- Authors: Ilango S, Pillans P, Peel NM, Scott I, Gray LC, Hubbard RE
- Issue date: 2017 Sep